eFFECTOR Therapeutics, Inc.
(NASDAQ : EFTR)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Finance » Financial Conglomerates
symbolcompany%chnglast%shortavg$volume
CCitigroup, Inc. -0.13%69.911.0%$1170.24m
LCIDLucid Group, Inc. 8.46%22.960.0%$651.50m
AXPAmerican Express Co. 0.73%163.821.7%$550.17m
IRNTIronNet, Inc. -26.92%30.260.0%$410.45m
RIOTRiot Blockchain, Inc. -0.24%29.300.0%$311.41m
DOCNDigitalOcean Holdings, Inc. -5.89%81.500.0%$227.33m
OPADOfferpad Solutions, Inc. -30.67%13.850.0%$212.12m
PRUPrudential Financial, Inc. -0.41%103.191.5%$180.61m
TMCTMC the metals co., Inc. -16.22%10.380.0%$163.80m
KPLTKatapult Holdings, Inc. 1.58%6.430.0%$133.82m
RKLBRocket Lab USA, Inc. -3.02%15.410.0%$123.40m
EFTReFFECTOR Therapeutics, Inc. -1.43%19.300.0%$95.21m
EQHEquitable Holdings, Inc. -1.12%29.150.0%$79.48m
STEMStem, Inc. 9.01%25.880.8%$65.06m
SRNGSoaring Eagle Acquisition Corp. 0.00%11.420.0%$64.58m

Company Profile

eFFECTOR Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of a new class oncology drugs known as selective translation regulator inhibitors (STRIs). Its STRI product candidates target the eIF4F complex and its activating kinase, mitogen-activated protein kinase 1/2 (MNK 1/2). The company was founded by Kevan Shokat, Davide Ruggero, and Siegfried Reich on May 1, 2012 and is headquartered in San Diego, CA.